Brief: Advicenne SA Presented Additional Efficacy Data On Adv7103
Oct 28 (Reuters) - Advicenne SA ADVIC.PA :
* ADVICENNE PRESENTED ADDITIONAL EFFICACY DATA ON ADV7103 IN
TREATMENT OF DRTA AT INTERNATIONAL PEDIATRIC NEPHROLOGY
ASSOCIATION CONGRESS
* RESULTS ON PLASMA BICARBONATE SHOWED THAT 82.4% (14/17) OF
NON
RESPONDER (I.E. PATIENT UNABLE TO ACHIEVE ADEQUATE CORRECT ION
OF PLASMA BICARBONATE) BECAME RESPONDER WHEN SWITCHING FROM SOC
TO ADV7103
Source text for Eikon: ID:
Further company coverage: ADVIC.PA
((sudip.kargupta@thomsonreuters.com;))
Recent news on Advicenne SA
See all newsBrief: Advicenne Secures Cash Runway To Q2 2027 Through Bond Financing Of Amount Of Up To €3.8 Mln
Corrected: BRIEF-Advicenne FY Net Income EUR -9.532 Million (March 26)
France's Advicenne 2025 sales rise, net loss widens
Brief: Advicenne FY Net Income EUR -9.532 Million
Brief: Advicenne SA -Cash Position Of EUR 2.0 Million With Unchanged Financial Visibility In Q1 2025